InnoVen Capital, the venture debt firm backed by Temasek and UOB, sees considerable opportunities in Southeast Asia's entrepreneurial community, which the firm's CEO for Singapore and Southeast Asia Chin Chao sees as improving faster than expected.
"It's been a pleasant surprise for me that the founding and management teams are so much stronger than they have been in the past. And a lot of them have startup experience," said Chao, who joined InnoVen...
India’s Innoven Capital, a joint venture between UOB and Temasek Holdings-owned Seviora Holdings, has fractionalised a USD 50m venture debt fund using blockchain and smart contracts.
OneVentures and UniQuest have led a AUD 34m (USD 23m) funding round for Vaxxas, an Australia-based biotechnology company running clinical programmes that include a needle-free COVID-19 vaccine candidate.
Temasek Holdings, A91 Partners, and Kae Capital have invested USD 135m in Indian omnichannel wellness products retailer HealthKart.